UNSPSC 51132102: Aspirin/dipyridamole

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class BL117. This VA Drug Class (BL117) classifies this compound as belonging to the group PLATELET AGGREGATION INHIBITORS.

UNSPSC 51132102 Aspirin/dipyridamole is a Commodity code that nominally covers pharmaceutical products, but the recent state and local opportunities record shows no solicitations for aspirin or dipyridamole itself. The single recent opportunity—Sourcewell RFP #061626, posted May 12, 2026 with a June 16, 2026 response deadline—is tagged to this code but solicits law enforcement equipment, which falls entirely outside the pharmaceutical scope. This code shows no relevant recent activity in state and local procurement.

The mismatch between the code's pharmaceutical classification and the law enforcement equipment solicitation suggests either a classification error in the opportunity posting or a data artifact with no bearing on aspirin/dipyridamole procurement patterns. Business development professionals should verify independently whether state and local demand for aspirin/dipyridamole typically flows through this code or through alternative pharmaceutical supply-chain vehicles such as cooperative purchasing agreements with group purchasing organizations or standing supplier contracts managed at the department level. The absence of genuine pharmaceutical solicitations under this Commodity code limits visibility into actual state and local buying patterns for this product line.